NexgenRX Inc. (NXG) — Cash Flow Reinvestment Rate
NexgenRX Inc. (NXG) has a Cash Flow Reinvestment Rate of 0.06x as of September 2025, reinvesting CA$55.65K (capex CA$18.07K plus investments CA$-37.58K) from operating cash flow of CA$880.82K. Check earnings quality score of NexgenRX Inc. to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NexgenRX Inc. Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for NexgenRX Inc. across 8 annual periods. Explore NexgenRX Inc. (NXG) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for NexgenRX Inc. (2013–2024)
Year-by-year capital reinvestment analysis for NexgenRX Inc.. For live market cap and broader valuation context, see market cap of NexgenRX Inc..
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.43x | CA$498.33K | CA$1.15 Million | CA$317.69K | ▲ +122.8% |
| 2023 | 0.19x | CA$248.41K | CA$1.28 Million | CA$248.41K | ▼ -76.8% |
| 2022 | 0.84x | CA$895.42K | CA$1.07 Million | CA$388.81K | ▲ +114.7% |
| 2021 | 0.39x | CA$1.50 Million | CA$3.82 Million | CA$126.55K | ▼ -13.4% |
| 2020 | 0.45x | CA$1.20 Million | CA$2.65 Million | CA$120.74K | ▼ -53.1% |
| 2019 | 0.96x | CA$1.01 Million | CA$1.05 Million | CA$50.78K | ▼ -33.4% |
| 2016 | 1.45x | CA$710.00K | CA$490.96K | CA$355.00K | ▲ +2269.5% |
| 2013 | 0.06x | CA$47.24K | CA$774.08K | CA$47.24K | — |